BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 16707188)

  • 1. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
    Wang J; Tabata Y; Morimoto K
    J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
    Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
    J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
    Wu J; Wei W; Wang LY; Su ZG; Ma GH
    Biomaterials; 2007 Apr; 28(13):2220-32. PubMed ID: 17291582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a sperminated gelatin on the nasal absorption of insulin.
    Seki T; Kanbayashi H; Chono S; Tabata Y; Morimoto K
    Int J Pharm; 2007 Jun; 338(1-2):213-8. PubMed ID: 17346909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies to improve the intranasal absorption of insulin.
    Duan X; Mao S
    Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
    Preda M; Leucuta SE
    J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of in situ gel system for nasal insulin delivery.
    Agrawal AK; Gupta PN; Khanna A; Sharma RK; Chandrawanshi HK; Gupta N; Patil UK; Yadav SK
    Pharmazie; 2010 Mar; 65(3):188-93. PubMed ID: 20383938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A
    Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of microneedles for percutaneous absorption of insulin.
    Ito Y; Hagiwara E; Saeki A; Sugioka N; Takada K
    Eur J Pharm Sci; 2006 Sep; 29(1):82-8. PubMed ID: 16828268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
    du Plessis LH; Kotzé AF; Junginger HE
    Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microencapsulated chitosan nanoparticles for lung protein delivery.
    Grenha A; Seijo B; Remuñán-López C
    Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocytes as oral delivery systems for human insulin.
    Al-Achi A; Greenwood R
    Drug Dev Ind Pharm; 1998 Jan; 24(1):67-72. PubMed ID: 15605599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs.
    Morimoto K; Chono S; Kosai T; Seki T; Tabata Y
    Drug Deliv; 2008 Feb; 15(2):113-7. PubMed ID: 18293197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aminated gelatin on the nasal absorption of insulin in rats.
    Seki T; Kanbayashi H; Nagao T; Chono S; Tomita M; Hayashi M; Tabata Y; Morimoto K
    Biol Pharm Bull; 2005 Mar; 28(3):510-4. PubMed ID: 15744079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.